Download PDF
Semin Respir Crit Care Med 2000; Volume 21(Number 05): 451-462
DOI: 10.1055/s-2000-9407
Copyright © 2000 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Evaluation and Management of the Complications of Lung Cancer Treatment

Mei-Lin W. Ah-See1 , Stephen G. Spiro2
  • 1Clinical Oncology, The Middlesex Hospital, University College London Hospitals, London, United Kingdom
  • 2Department of Respiratory Medicine, The Middlesex Hospital, University College London Hospitals, London, United Kingdom
Further Information

Publication History

Publication Date:
31 December 2000 (online)

    Permissions and Reprints

ABSTRACT

The principal treatment-related complications encountered in the management of lung cancer are presented with particular reference to surgery, radiotherapy, and chemotherapy. The clinical features, risk factors, and management of the complications are discussed.

KEYWORD

Lung cancer - surgery - radiotherapy - chemotherapy - complications

REFERENCES

  • 1 McIntosh H C, Spitz S. A study of radiation pneumonitis.  AJR . 1939;  41 605-615
    PubMedSearch in Google Scholar
  • 2 Van der Kogel A J, Ang K K. Complications related to radiotherapy. In: Peckham M, Pinedo H, Veronesi U, eds. Oxford Textbook of Oncology Oxford: Oxford University Press, 1995: 2295-306
    Search in Google Scholar
  • 3 Pearson F G. Current status of surgical resection for lung cancer.  Chest . 1994;  106 337-339S
    PubMedSearch in Google Scholar
  • 4 Silverberg E, Boring C C, Squires T S. Cancer Statistics.  CA Cancer J Clin . 1990;  40 9-26
    PubMedSearch in Google Scholar
  • 5 Deslauriers J, Ginsberg R J, Fournier B. Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer.  Chest . 1994;  106 329-330S
    PubMedSearch in Google Scholar
  • 6 Ginsberg R J, Hill L D, Eagan R T. Modern thirty-day operative mortality for surgical resection in lung cancer.  J Thorac Cardiovasc Surg . 1983;  86 654-658
    CrossrefPubMedSearch in Google Scholar
  • 7 Markos J, Mullan B P, Hillman D R. Preoperative assessment as a predictor of mortality and morbidity after lung resection.  Am Rev Respir Dis . 1989;  139 902-910
    CrossrefPubMedSearch in Google Scholar
  • 8 Nagasaki F, Flehinger B J, Martini N. Complications of surgery in the treatment of carcinoma of the lung.  Chest . 1982;  82 25-29
    CrossrefPubMedSearch in Google Scholar
  • 9 Wyser C, Stulz P, Soler M. Prospective evaluation of an algorithm for the functional assessment of lung resection candidates.  Am J Respir Crit Care Med . 1999;  159 1450-1456
    CrossrefPubMedSearch in Google Scholar
  • 10 Van der Kogel A J. Radiation response and tolerance of normal tissues.  In: Steel GG, ed. Basic Clinical Radiobiology. London: Arnold; . 1997;  30-39
    PubMedSearch in Google Scholar
  • 11 Movsas B, Raffin T A, Epstein A H. Pulmonary radiation injury.  Chest . 1997;  111 1061-1076
    PubMedSearch in Google Scholar
  • 12 Davies S D, Yankelevitz D F, Henschke C I. Radiation effects on the lung: Clinical features, Pathology, and Imaging Findings.  AJR . 1992;  159 1157-1164
    PubMedSearch in Google Scholar
  • 13 Van Houtte P. Mornex P. Radiotherapy of non-small-cell and small-cell and SCLC. Lung cancer. In: Spiro SG, ed. Carcinoma of the Lung. European Respiratory Monograph, vol. 1 Oct. 1995: 241-268
    Search in Google Scholar
  • 14 Fried J R, Goldberg H. Post-irradiation changes in the lung and thorax.  Am J Roentgenol . 1940;  43 877-895
    PubMedSearch in Google Scholar
  • 15 Ross W M. Radiotherapeutic and radiological aspects of radiation fibrosis of the lungs.  Thorax . 1956;  11 241-246
    PubMedSearch in Google Scholar
  • 16 Libshitz H I, Southard M E. Complications of radiation therapy: The thorax.  Semin Roentgenol . 1974;  9 41-49
    PubMedSearch in Google Scholar
  • 17 Roswit B, White D C. Severe radiation injuries of the lung.  AJR . 1977;  129 127-136
    PubMedSearch in Google Scholar
  • 18 Bate D, Guttemann R J. Changes in the lung and pleura following 2-million volt therapy for carcinoma of the breast.  Radiology . 1957;  69 372-382
    PubMedSearch in Google Scholar
  • 19 Bachman A L, Macken K. Pleural effusions following supervoltage radiation for breast carcinoma.  Radiology . 1959;  72 699-709
    PubMedSearch in Google Scholar
  • 20 Libshitz H I, Southard M E. Complications of radiation therapy: The thorax.  Semin Roentgenol . 1974;  9 41-49
    PubMedSearch in Google Scholar
  • 21 Pagani J J, Libshitz H I. CT manifestations of radiation-induced change in chest tissue.  J Comput Assist Tomogr . 1982;  6 243-248
    PubMedSearch in Google Scholar
  • 22 Libshitz H I, Shuman L S. Radiation-induced pulmonary change: CT findings.  J Comput Assist Tomogr . 1984;  8 15-19
    PubMedSearch in Google Scholar
  • 23 Mah K, Poon P Y, Van Dyk J. Assessment of acute radiation-induced pulmonary changes using computed tomography.  J Comput Assist Tomogr . 1986;  10 736-743
    PubMedSearch in Google Scholar
  • 24 Bourgouin P, Cousineau G, Lemire P. Differentiation of radiation-induced fibrosis from recurrent pulmonary neoplasm by CT.  Can Assoc Radiol J . 1987;  38 23-26
    PubMedSearch in Google Scholar
  • 25 Ikezoe J, Takashima S, Morimoto S. CT appearance of acute radiation-induced injury in the lung.  AJR . 1988;  150 765-770
    PubMedSearch in Google Scholar
  • 26 Bell J, McGivern D, Bullimore J. Diagnostic imaging of post-irradiation changes in the chest.  Clin Radiol . 1988;  39 109-119
    CrossrefPubMedSearch in Google Scholar
  • 27 Frija J, Ferme C, Baud L. Radiation-induced lung injuries: A survey of computed tomography and pulmonary function tests in 18 cases of Hodgkin's disease.  Eur J Radiol . 1988;  8 18-23
    PubMedSearch in Google Scholar
  • 28 Ikezoe J, Morimoto S, Takashima S. Acute radiation-induced pulmonary injury: Computed tomography evaluation.  Semin Ultrasound CT MR . 1990;  11 409-416
    PubMedSearch in Google Scholar
  • 29 Glazer H S, Lee J KT, Levitt R G. Radiation fibrosis: Differentiation from recurrent tumor by MR imaging.  Radiology . 1985;  156 721-726
    PubMedSearch in Google Scholar
  • 30 Kataoka M, Kawamura M, Itho H. Ga-67 citrate scintigraphy for the early detection of radiation pneumonitis.  Clin Nucl Med . 1992;  17 27-31
    PubMedSearch in Google Scholar
  • 31 Evans R F, Sagerman R H, Ringrose T L. Pulmonary function following mantle-field irradiation for Hodgkin's disease.  Radiology . 1974;  111 729-731
    PubMedSearch in Google Scholar
  • 32 Brady L W, German P A, Cander L. The effects of radiation therapy on pulmonary function in carcinoma of the lung.  Radiology . 1965;  85 130-134
    PubMedSearch in Google Scholar
  • 33 Watchie J, Coleman C N, Raffin T A. Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease.  Int J Radiat Oncol Biol Phys . 1987;  13 517-524
    PubMedSearch in Google Scholar
  • 34 Lokich J J, Brass H, Eberly F E. The pulmonary effect of mantle irradiation in patients with Hodgkin's disease.  Radiology . 1973;  108 397-402
    PubMedSearch in Google Scholar
  • 35 Host H, Vale J R. Lung function after mantle field irradiation in Hodgkin's disease.  Cancer . 1973;  32 328-332
    PubMedSearch in Google Scholar
  • 36 Wolin E M, Rosenberg S A, Kaplan H S. A randomized comparison of PAVe and MOP (P) as adjuvant therapy for Hodgkin's disease. In: Salmon SE, Jones SE, eds. Adjuvant Therapy of Cancer New York: Grune & Stratton, 1979: 119-127
    Search in Google Scholar
  • 37 Rubin O, Casarett G W. Clinical Radiation Pathology.  Philadelphia: WB Saunders, 1968: 423-470
    Search in Google Scholar
  • 38 Gross N J, Narine K R, Wade R. Protective effect of corticosteroids on radiation pneumonitis in mice.  Radiat Res . 1988;  113 112-119
    PubMedSearch in Google Scholar
  • 39 Gross N J. Pulmonary effects of radiation therapy.  Ann Intern Med . 1977;  86 81-92
    PubMedSearch in Google Scholar
  • 40 Castellino R A, Glastein E, Turbow M M. Latent radiation injury of lungs or heart activated by steroid withdrawal.  Ann Intern Med . 1974;  80 593-599
    PubMedSearch in Google Scholar
  • 41 Rotstein S, Blomgren H, Baral E. Incidence of infectious symptoms after radiation therapy for breast cancer: Long-term effects.  Acta Oncol . 1987;  26 197-201
    PubMedSearch in Google Scholar
  • 42 Gross N j, Holloway N O, Narine K R. Effects of nonsteroidal anti-inflammatory agents on experimental radiation pneumonitis.  Radiat Res . 1991;  127 317-324
    PubMedSearch in Google Scholar
  • 43 Coggle J E, Lambert B E, Moores S R. Radiation effects in the lung.  Environ Health Perspect . 1986;  70 261-291
    PubMedSearch in Google Scholar
  • 44 Gross N J. Pulmonary effects of radiation therapy.  Ann Intern Med . 1977;  86 81-92
    PubMedSearch in Google Scholar
  • 45 Roswitt B, White D C. Severe radiation injuries of the lung.  AJR . 1977;  129 127-136
    PubMedSearch in Google Scholar
  • 46 Bennett D E, Million R R, Ackerman L V. Bilateral radiation pneumonitis, a complication of the radiotherapy of bronchogenic carcinoma.  Cancer . 1969;  23 1001-1018
    PubMedSearch in Google Scholar
  • 47 Stone D J, Schwartz M J, Green R A. Fatal pulmonary insufficiency due to radiation effect upon the lung.  Am J Med . 1956;  21 211-226
    CrossrefPubMedSearch in Google Scholar
  • 48 Whitfield G W, Bond W H, Arnott W M. Radiation reactions in the lung.  Q J Med . 1956;  97 69-86
    PubMedSearch in Google Scholar
  • 49 Kaufman J, Komorowski R. Bronchiolitis obliterans, a new clinical-pathologic complication of irradiation pneumonitis.  Chest . 1990;  97 1243-1244
    PubMedSearch in Google Scholar
  • 50 Crestani B, Kambouchner M, Soler P. Migratory bronchiolitis obliterans organizing pneumonia after unilateral radiation therapy for breast carcinoma.  Eur Respir J . 1995;  8 318-321
    CrossrefPubMedSearch in Google Scholar
  • 51 Bayle J Y, Nesme P, Bejui-Thivolet F. Migratory organizing pneumonitis ``primed'' by radiation therapy.  Eur Respir J . 1995;  8 322-326
    CrossrefPubMedSearch in Google Scholar
  • 52 Van Laar J M, Holscher H C, Van Krieken J HJM. Bronchiolitis obliterans organizing pneumonia after adjuvant radiotherapy for breast carcinoma.  Respir Med . 1997;  91 241-244
    PubMedSearch in Google Scholar
  • 53 Crestani B, Valeyre D, Roden S. Bronchiolitis obliterans organising pneumonia syndrome primed by radiation therapy to the breast.  Am J Respir Crit Care Med . 1998;  158 1929-1935
    CrossrefPubMedSearch in Google Scholar
  • 54 Martin C, Romero S, Sanchez-Paya J. Bilateral lymphocytic alveolitis: A common reaction after unilateral thoracic irradiation.  Eur Respir J . 1999;  13 727-732
    CrossrefPubMedSearch in Google Scholar
  • 55 Prakash U BS. Radiation-induced injury in the ``nonirradiated'' lung.  Eur Respir J . 1999;  13 715-717
    CrossrefPubMedSearch in Google Scholar
  • 56 Stewart J R, Fajardo L F. Radiation-induced heart disease: An update.  Prog Cardiovasc Dis . 1984;  27 173-194
    PubMedSearch in Google Scholar
  • 57 Schultz-Hector S. Heart. In: Scherer E, Streffer C, Trott KR, eds. Radiopathology of Organs and Tissues Berlin: Springer-Verlag, 1991: 347-368
    Search in Google Scholar
  • 58 Brosius F C, Waller B F, Roberts W L. Analysis of 16 young (aged 15-33 years) necropsy patients who received over 3500 rads to the heart.  Am J Med . 1981;  70 519-530
    CrossrefPubMedSearch in Google Scholar
  • 59 PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials.  Lancet . 1998;  352 257-263
    CrossrefPubMedSearch in Google Scholar
  • 60 Dautzenberg B, Arriagada R, Chammard A B. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma.  Cancer . 1999;  86 265-273
    CrossrefPubMedSearch in Google Scholar
  • 61 Van der Kogel AJ. The nervous system: Radiobiology and experimental pathology. In: SchererE, Streffer C, Trott, eds. Radiopathology of Organs and Tissues Heidelberg: Springer-Verlag, 1991: 191-212
    Search in Google Scholar
  • 62 Macbeth F R, Wheldon, T E, Girling D J. Radiation myelopathy: Estimates of risk in 1048 patients in three randomised trials of palliative radiotherapy for non-small cell lung cancer.  Clin Oncol . 1996;  8 176-181
    CrossrefPubMedSearch in Google Scholar
  • 63 Glantz M J, Choy H, Yee L. Prophylactic cranial irradiation in small cell lung cancer: Rationale, results, and recommendations.  Semin Oncol . 1997;  24 477-483
    PubMedSearch in Google Scholar
  • 64 Auperin A, Arriagada R, Pignon J P. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.  N Engl J Med . 1999;  341 476-484
    CrossrefPubMedSearch in Google Scholar
  • 65 Feld R, Clamon G H, Blunn R. Short course prophylactic cranial irradiation for small cell lung cancer.  Am J Clin Oncol . 1985;  8 371-376
    PubMedSearch in Google Scholar
  • 66 Posner J B. Neurologic Complications of Cancer.  Philadelphia, PA: FA Davies, 1995: 96-100
    Search in Google Scholar
  • 67 Perez C A, Einhorn L, Oldham R K. Randomized trial of radiotherapy to the thorax in limited small cell carcinoma of the lung treated with multiagent chemotherapy and elective brain irradiation: A preliminary report.  J Clin Oncol . 1984;  2 1200-1208
    PubMedSearch in Google Scholar
  • 68 Catane R, Schwade J G, Yarr I. Follow-up and neurological evaluation in patients with small cell lung carcinoma treated with prophylactic cranial irradiation and chemotherapy.  Int J Radiat Oncol Biol Phys . 1981;  7 105-109
    PubMedSearch in Google Scholar
  • 69 Johnson B E, Patronas N, Hayes W. Neurologic, computed cranial tomographic, and magnetic resonance imaging abnormalities in patients with small-cell lung carcinoma: Further follow-up of 6- to 13-year survivors.  J Clin Oncol . 1990;  8 48-56
    PubMedSearch in Google Scholar
  • 70 Lee J S, Umsawasdi T, Lee Y Y. Neurotoxicity in long-term survivors of small cell lung cancer.  Int J Radiat Oncol Biol Phys . 1986;  12 313-321
    PubMedSearch in Google Scholar
  • 71 Lishner M, Feld R, Payne D G. Late neurological complications after prophylactic cranial irradiation in patients with small-cell lung cancer: The Toronto experience.  J Clin Oncol . 1990;  8 215-221
    PubMedSearch in Google Scholar
  • 72 Frytak S, Shaw J N, O'Neill B P. Leukoencephalopathy in small cell lung cancer patients receiving prophylactic cranial irradiation.  Am J Clin Oncol . 1989;  12 27-33
    PubMedSearch in Google Scholar
  • 73 Ahles T A, Silberfarb P M, Herndon II J. Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: A study by the Cancer and Leukaemia Group B.  J Clin Oncol . 1998;  16 1954-1960
    PubMedSearch in Google Scholar
  • 74 Arriagada R, Le Chevalier T, Borie F. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission.  J Natl Cancer Inst . 1995;  87 183-190
    CrossrefPubMedSearch in Google Scholar
  • 75 Gregor A, Cull A, Stephens R J. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial.  Eur J Cancer . 1997;  33 1752-1758
    CrossrefPubMedSearch in Google Scholar
  • 76 Johnson B E, Cortazar P, Chute J P. Second lung cancers in patients successfully treated for lung cancer.  Semin Oncol . 1997;  24 1-9
    PubMedSearch in Google Scholar
  • 77 Van Bodegom P Cv, Wagenaar S S, Corrin B. Second primary lung cancer: Importance of long term follow up.  Thorax . 1989;  44 788-793
    PubMedSearch in Google Scholar
  • 78 Sugimura H, Watanabe S, Tsugane S. Case-control study on histologically determined multiple primary lung cancer.  J Natl Cancer Inst . 1987;  79 435-441
    PubMedSearch in Google Scholar
  • 79 Mathisen D J, Jensik R J, Faber L P. Survival following resection for second and third primary lung cancers.  J Thorac Cardiovasc Surg . 1984;  82 502-510
    PubMedSearch in Google Scholar
  • 80 Wu S C, Lin Z Q, Xu C W. Multiple primary lung cancers.  Chest . 1987;  92 892-896
    PubMedSearch in Google Scholar
  • 81 Deschamps C, Pairolero P C, Trastek V F. Multiple primary lung cancers: Results of surgical treatment.  Ann Thorac Cardiovasc Surg . 1990;  99 769-778
    CrossrefPubMedSearch in Google Scholar
  • 82 Abrahamsen J F, Andersen A, Hannisdal E. Second malignancies after treatment of Hodgkin's Disease: The influence of treatment, follow-up time, and age.  J Clin Oncol . 1993;  11 255-261
    PubMedSearch in Google Scholar
  • 83 Swerdlow A J, Douglas A J, Vaughan Hudson G. Risk of second primary cancers after Hodgkin's Disease by type of treatment: Analysis of 2846 patients in the British National Lymphoma Investigation.  Br Med J . 1992;  304 1137-1143
    PubMedSearch in Google Scholar
  • 84 Tucker M A, Coleman C N, Cox R S. Risk of second cancers after treatment for Hodgkin's Disease.  N Engl J Med . 1988;  318 76-81
    PubMedSearch in Google Scholar
  • 85 Van Leeuwen F E, Klikman W J, Hagenbeek A. Second cancer risk following Hodgkin's Disease: A 20-year follow-up study.  J Clin Oncol . 1994;  12 312-325
    PubMedSearch in Google Scholar
  • 86 Kirova Y M, FeuilhadeF, Calitchi E. Radiation-induced sarcoma after breast cancer. Apropos of 8 cases and review of the literature.  Cancer-Radiother . 1998;  2 381-386
    PubMedSearch in Google Scholar
  • 87 Ihde D c. Drug therapy. Chemotherapy for lung cancer.  N Engl J Med . 1992;  12 1434-1441
    PubMedSearch in Google Scholar
  • 88 Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials.  Br Med J . 1995;  11 899-909
    PubMedSearch in Google Scholar
  • 89 Smit E F, Postmus P E. Chemotherapy of small cell lung cancer. In: Carney DN, ed. Lung cancer London: Edward Arnold, 1995: 156-172
    Search in Google Scholar
  • 90 Rosell R, Gomez-Codina J, Camps C. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small-cell lung cancer.  N Engl J Med . 1994;  330 153-158
    CrossrefPubMedSearch in Google Scholar
  • 91 Roth J A, Fossell F, Komaki R. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.  J Natl Cancer Inst . 1994;  86 673-680
    CrossrefPubMedSearch in Google Scholar
  • 92 Weiss R B, Vogelzang N J. Miscellaneous toxicities. In: Devita, VT Jnr, Hellman S, Rosenberg SA, eds. Cancer. Principles and Practice of Oncology Philadelphia: JB Lippincott Company, 1993: 2349-2358
    Search in Google Scholar
  • 93 Steinherz L J, Yahalom J. Cardiac complications of cancer therapy. In: Devita, VT Jnr, Hellman S, Rosenberg SA, eds. Cancer. Principles and Practice of Oncology Philadelphia: JB Lippincott Company, 1993: 2370-2385
    Search in Google Scholar
  • 94 Talcott J A, Finberg R, Mayer R J. The medical course of cancer patients with fever and neutropenia: Clinical identification of a low-risk subgroup at presentation.  Arch Intern Med . 1988;  148 2561-2568
    CrossrefPubMedSearch in Google Scholar
  • 95 Talcott J A, Siegel R D, Finberg R. Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule.  J Clin Oncol . 1992;  10 316-322
    PubMedSearch in Google Scholar
  • 96 Freifeld A, Marchigiani D, Walsh T. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.  N Engl J Med . 1999;  341 305-311
    CrossrefPubMedSearch in Google Scholar
  • 97 Kern W V, Cometta A, De Bock R. Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy.  N Engl J Med . 1999;  341 312-318
    CrossrefPubMedSearch in Google Scholar
  • 98 Hirsch F R, Hansen H H, Hansen M. The superiority of combination chemotherapy including etoposide based on in vivo cycle analysis in the treatment of small-cell lung cancer: A randomised trial of 288 consecutive patients.  J Clin Oncol . 1987;  5 585-591
    PubMedSearch in Google Scholar
  • 99 Stephens R J, Girling D J, Machin D. Treatment related deaths in small cell lung cancer trials: Can patients at risk be identified?.  Lung Cancer . 1994;  11 259-274
    CrossrefPubMedSearch in Google Scholar
  • 100 Morittu L, Earl H M, Souhami R L. Patients at risk of chemotherapy-associated toxicity in small cell lung cancer.  Br J Cancer . 1989;  59 801-804
    PubMedSearch in Google Scholar
  • 101 Johnson D H. Small cell lung cancer in the elderly patient.  Semin Oncol . 1997;  24 484-491
    PubMedSearch in Google Scholar
  • 102 Urban T, Lebeau B. Colony-stimulating factor therapy and febrile neutropenia induced by chemotherapy: Need for economical studies.  Eur Respir J . 1999;  13 1228-1229
    PubMedSearch in Google Scholar
  • 103 Crawford J, Ozer H, Stoller R. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.  N Engl J Med . 1991;  325 164-170
    CrossrefPubMedSearch in Google Scholar
  • 104 Trillet-Lehoir V, Green J, Manegold C. Recombinant granulocyte colony-stimulating factor reduces the infectious complications of cytotoxic chemotherapy.  Eur J Cancer . 1993;  29 319-324
    CrossrefPubMedSearch in Google Scholar
  • 105 Maher D W, Lieschke G J, Green M. Filgrastim in patients with chemotherapy-induced febrile neutropenia. A double-blind, placebo-controlled trial.  Ann Intern Med . 1994;  121 492-501
    PubMedSearch in Google Scholar
  • 106 Mayordomo J I, Rivera F, Diaz-Puente M. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.  J Natl Cancer Inst . 1995;  87 803-808
    PubMedSearch in Google Scholar
  • 107 Anaissie E J, Vartivarian S, Bodey G P. Randomized comparison between antibiotics alone and antibiotics plus granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) in cancer patients with fever and neutropenia.  Am J Med . 1996;  100 17-23
    CrossrefPubMedSearch in Google Scholar
  • 108 Cooper J AD, White D A, Matthay R A. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs.  Am Rev Respir Dis . 1986;  133 321-340
    PubMedSearch in Google Scholar
  • 109 Israel-Biet D, Labrune S, Huchon, G J. Drug-induced lung disease: 1990 review.  Eur Respir J . 1991;  4 465-478
    PubMedSearch in Google Scholar
  • 110 Foucher P, Biour M, Blayac J P. Drugs which may injure the respiratory system.  Eur Respir J . 1997;  10 265-279
    CrossrefPubMedSearch in Google Scholar
  • 111 Hesketh P J, Gandara. A new class of antiemetic agents.  J Natl Cancer Inst . 1991;  83 613-620
    PubMedSearch in Google Scholar